Home Symposiums / Research Seminars / Workshop

Research Seminar 16 Nov 2017

Print


Research Seminar

Centre for Genomic Sciences

Leveraging Consumer Genetics Tests
Towards Precision Medicine

Dr Lasse Folkersen

Assistant Professor
Technical University of Denmark, Denmark

16 November 2017 (Thu)
3:00 - 4:00 pm


Seminar Room 1A, G/F
The Hong Kong Jockey Club Building for Interdisciplinary Research
5 Sassoon Road, Pokfulam, Hong Kong

 
Abstract:

Precision medicine is rapidly gaining prominence. This is driven by successes in cancer research, wherein cancer-genome sequencing allows targeting of very specific tumor types. In non-cancer, development is lagging, likely because the germ-line genome has relatively lower impact on current disease state. Often biomarker tests are not worth the trouble. But large-scale systematized and pre-measured, we believe that easily available genomics measurements can nonetheless bring benefit to the primary stages of health care. Systems are therefore needed to automatically provide only relevant and timely information, and to do so in the context of already existing electronic health record system (EHR) of Denmark. Therefore, the overall objective of this talk is to cover the de-centralized use of genetic precision medicine data: implementing feasible precision medicine one patient at the time.


About the Speaker:

Lasse Folkersen, geneticists and bioinformatician, graduated from the medical department of Karolinska Institute, Sweden in 2011. The overarching research theme is use of high-throughput omics to bridge the gap between research and medicine. Main interests are in genetic and transcriptomic profiles of patients, and their possibilities for translating genetics to medical use. This resulted in co-authorship of many early cardiovascular genome-wide association efforts, as well as several papers on predicting patient-groups. Further steps into industrial drug and pharmacogenetics development from the technique, produced articles on drug development and precision medicine in autoimmune diseases and accompanying patents during work for Novo Nordisk, and from 2014 for the Department of Bioinformatics at Technical University of Denmark. Currently co-author of 100+ papers on subjects focused the goal of translating omics-technologies into medical use, including functional genetics and precision medicine.

 

ALL ARE WELCOME

For enquiries, please call 2831-5500 or write to This e-mail address is being protected from spambots. You need JavaScript enabled to view it